Bulletin
Investor Alert

New York Markets Close in:

Novavax Inc.

NAS: NVAX

GO
/marketstate/country/us

Market open

 --Real time quotes

Sep 21, 2020, 12:36 p.m.

/zigman2/quotes/202614340/composite

$

110.00

Change

+1.64 +1.51%

Volume

Volume 1.98m

Real time quotes

/zigman2/quotes/202614340/composite

Previous close

$ 108.36

$ 110.00

Change

+1.64 +1.51%

Day low

Day high

$102.10

$110.18

Open

52 week low

52 week high

$3.54

$189.40

Open

Insider Actions for Novavax Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
08/18/2020 Gary C. Evans
Director
10,500   Disposition at $150.44 per share. 1,579,620
08/18/2020 Michael A. McManus
Director
8,000   Disposition at $146 per share. 1,168,000
08/18/2020 John J. Trizzino
EVP, CBO and CFO
1,300   Disposition at $153.95 per share. 200,135
08/18/2020 John J. Trizzino
EVP, CBO and CFO
1,708   Disposition at $153.16 per share. 261,597
08/18/2020 John J. Trizzino
EVP, CBO and CFO
4,199   Disposition at $152.22 per share. 639,171
08/18/2020 John J. Trizzino
EVP, CBO and CFO
4,010   Disposition at $150.85 per share. 604,908
08/18/2020 John J. Trizzino
EVP, CBO and CFO
1,800   Disposition at $149.83 per share. 269,694
08/18/2020 John J. Trizzino
EVP, CBO and CFO
6,600   Disposition at $149.08 per share. 983,928
08/18/2020 John J. Trizzino
EVP, CBO and CFO
9,101   Disposition at $147.99 per share. 1,346,856
08/18/2020 John J. Trizzino
EVP, CBO and CFO
8,094   Disposition at $146.95 per share. 1,189,413
08/18/2020 John J. Trizzino
EVP, CBO and CFO
4,900   Disposition at $146.21 per share. 716,429
08/18/2020 John J. Trizzino
EVP, CBO and CFO
300   Disposition at $143.99 per share. 43,197
08/18/2020 John J. Trizzino
EVP, CBO and CFO
776   Disposition at $142.85 per share. 110,851
08/18/2020 Gregory M. Glenn
President, R&D
525   Disposition at $146.58 per share. 76,954
08/18/2020 Gregory M. Glenn
President, R&D
17,151   Disposition at $146 per share. 2,504,046
08/18/2020 Gregory M. Glenn
President, R&D
31,957   Disposition at $145 per share. 4,633,765
08/18/2020 Gregory M. Glenn
President, R&D
6,288   Disposition at $143.94 per share. 905,094
08/18/2020 John A. Herrmann
EVP, Chief Legal Officer
21,648   Disposition at $144.79 per share. 3,134,413
08/18/2020 John A. Herrmann
EVP, Chief Legal Officer
24,594   Disposition at $143.92 per share. 3,539,568
08/18/2020 Gregory M. Glenn
President, R&D
1,528   Gift at $0 per share. 0
08/18/2020 Gary C. Evans
Director
4,000   Derivative/Non-derivative trans. at $27.6 per share. 110,400
08/18/2020 Gary C. Evans
Director
4,000   Derivative/Non-derivative trans. at $27.6 per share. 110,400
08/18/2020 Gary C. Evans
Director
1,500   Derivative/Non-derivative trans. at $36.6 per share. 54,900
08/18/2020 Gary C. Evans
Director
1,000   Derivative/Non-derivative trans. at $50 per share. 50,000
08/18/2020 Michael A. McManus
Director
4,000   Derivative/Non-derivative trans. at $27.6 per share. 110,400
08/18/2020 Michael A. McManus
Director
4,000   Derivative/Non-derivative trans. at $27.6 per share. 110,400
08/18/2020 John J. Trizzino
EVP, CBO and CFO
10,410   Derivative/Non-derivative trans. at $46 per share. 478,860
08/18/2020 John J. Trizzino
EVP, CBO and CFO
13,322   Derivative/Non-derivative trans. at $27.6 per share. 367,687
08/18/2020 John J. Trizzino
EVP, CBO and CFO
1,952   Derivative/Non-derivative trans. at $27 per share. 52,704
08/18/2020 John J. Trizzino
EVP, CBO and CFO
5,855   Derivative/Non-derivative trans. at $27 per share. 158,085
08/18/2020 John J. Trizzino
EVP, CBO and CFO
11,249   Derivative/Non-derivative trans. at $99.8 per share. 1,122,650
08/18/2020 Gregory M. Glenn
President, R&D
13,225   Derivative/Non-derivative trans. at $46 per share. 608,350
08/18/2020 Gregory M. Glenn
President, R&D
16,658   Derivative/Non-derivative trans. at $27.6 per share. 459,760
08/18/2020 Gregory M. Glenn
President, R&D
2,733   Derivative/Non-derivative trans. at $27 per share. 73,791
08/18/2020 Gregory M. Glenn
President, R&D
8,200   Derivative/Non-derivative trans. at $27 per share. 221,400
08/18/2020 Gregory M. Glenn
President, R&D
4,405   Derivative/Non-derivative trans. at $36.6 per share. 161,223
08/18/2020 Gregory M. Glenn
President, R&D
7,500   Derivative/Non-derivative trans. at $25.6 per share. 192,000
08/18/2020 Gregory M. Glenn
President, R&D
3,200   Derivative/Non-derivative trans. at $50 per share. 160,000
08/18/2020 John A. Herrmann
EVP, Chief Legal Officer
8,328   Derivative/Non-derivative trans. at $46 per share. 383,088
08/18/2020 John A. Herrmann
EVP, Chief Legal Officer
13,322   Derivative/Non-derivative trans. at $27.6 per share. 367,687
08/18/2020 John A. Herrmann
EVP, Chief Legal Officer
1,952   Derivative/Non-derivative trans. at $27 per share. 52,704
08/18/2020 John A. Herrmann
EVP, Chief Legal Officer
393   Derivative/Non-derivative trans. at $27 per share. 10,611
08/18/2020 John A. Herrmann
EVP, Chief Legal Officer
11,249   Derivative/Non-derivative trans. at $99.8 per share. 1,122,650
08/18/2020 John A. Herrmann
EVP, Chief Legal Officer
2,499   Derivative/Non-derivative trans. at $91 per share. 227,409
08/18/2020 John A. Herrmann
EVP, Chief Legal Officer
7,499   Derivative/Non-derivative trans. at $36.6 per share. 274,463
08/18/2020 John A. Herrmann
EVP, Chief Legal Officer
1,000   Derivative/Non-derivative trans. at $50 per share. 50,000
06/18/2020 Gregory M. Glenn
President, R&D
16,749   Disposition at $59.53 per share. 997,067
06/18/2020 Gregory M. Glenn
President, R&D
16,749   Derivative/Non-derivative trans. at $42.2 per share. 706,807
06/03/2020 James F. Young
Director
1,500   Acquisition at $48.83 per share. 73,245
05/18/2020 John A. Herrmann
EVP, Chief Legal Officer
5,462   Disposition at $49.44 per share. 270,041
05/18/2020 John A. Herrmann
EVP, Chief Legal Officer
7,499   Disposition at $49.44 per share. 370,750
05/18/2020 John A. Herrmann
EVP, Chief Legal Officer
5,462   Derivative/Non-derivative trans. at $27 per share. 147,474
05/18/2020 John A. Herrmann
EVP, Chief Legal Officer
7,499   Derivative/Non-derivative trans. at $25.6 per share. 191,974
03/08/2020 Stanley C. Erck
President and CEO; Director
1,992   Derivative/Non-derivative trans. at $12.48 per share. 24,860
03/08/2020 John J. Trizzino
EVP, CBO and CFO
181   Derivative/Non-derivative trans. at $12.48 per share. 2,258
03/08/2020 Gregory M. Glenn
President, R&D
294   Derivative/Non-derivative trans. at $12.48 per share. 3,669
03/08/2020 John A. Herrmann
EVP, Chief Legal Officer
174   Derivative/Non-derivative trans. at $12.48 per share. 2,171
03/08/2020 Stanley C. Erck
President and CEO; Director
6,072   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2020 John J. Trizzino
EVP, CBO and CFO
468   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2020 Gregory M. Glenn
President, R&D
760   Derivative/Non-derivative trans. at $0 per share. 0
03/08/2020 John A. Herrmann
EVP, Chief Legal Officer
449   Derivative/Non-derivative trans. at $0 per share. 0
01/31/2020 Gregory M. Glenn
President, R&D
1,250   Acquisition at $3.86 per share. 4,825
11/18/2019 Michael A. McManus
Director
3,929   Disposition at $3.82 per share. 15,008
09/17/2019 John A. Herrmann
EVP, Chief Legal Officer
3,643   Disposition at $7.07 per share. 25,756
09/13/2019 Gregory M. Glenn
President, R&D
9,620   Disposition at $6.18 per share. 59,451
09/11/2019 John J. Trizzino
EVP, CBO and CFO
5,578   Disposition at $5.72 per share. 31,906

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
26 Purchases
20 Sales
163,451
164,979
Last 6 months
30 Purchases
23 Sales
194,661
194,689
Last 12 months
35 Purchases
28 Sales
203,660
201,259

Officers and Executives

Mr. Stanley C. Erck
President, Chief Executive Officer & Director
Mr. John J. Trizzino
Executive VP, Chief Financial & Business Officer
Mr. Biegie Lee
Vice President-Information Technology
Dr. Gale E. Smith
Chief Scientist, VP-Pre-Clinical Research
Mr. Filip Dubovsky
Chief Medical Officer & Senior Vice President
Dr. Gregory M. Glenn
President-Research & Development
Dr. Timothy Jon Hahn
Senior Vice President-Process Technology
Dr. Ben Machielse
Executive Vice President-CMC
Mr. Russell P. Wilson
Senior Vice President-Business Development
Mr. Mervyn L. Hamer
Vice President-Manufacturing
Mr. Sven Arne Andréasson
Senior Vice President-Corporate Development
Dr. Cynthia N. Oliver
Senior VP-Process Development Operations
Mr. Brian Rosen
Senior Vice President-Commercial Strategy
Ms. Jody Lichaa
Senior Vice President-Quality Assurance
Mr. Iksung Cho
Vice President-Biostatistics
Mr. Chris Dunne
Vice President-Finance
Ms. Kathleen Callahan
Vice President-Regulatory Affairs
Dr. Rajiv Indravadan Modi
Director
Mr. Frank D. Czworka
Senior Vice President-Global Sales
Ms. Silvia Taylor
Senior VP-Investor Relations & Corporate Affairs
Ms. Jill Hoyt
Chief Human Resources Officer & Executive VP
Mr. John A. Herrmann
Chief Legal Officer & Executive Vice President
Ms. Erika Trahan
Senior Manager-Investor & Public Relations
Dr. James F. Young
Chairman
Mr. Michael A. McManus
Independent Director
Mr. David M. Mott
Independent Director
Mr. Gary C. Evans
Independent Director
Dr. Richard H. Douglas
Independent Director
Ms. Rachel K. King
Independent Director
Link to MarketWatch's Slice.